J Valadier
Overview
Explore the profile of J Valadier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alessi M, Juhan-Vague I, Valadier J, Philip Joet C, Holvoet P, Collen D
Thromb Haemost
. 1988 Apr;
59(2):346-7.
PMID: 3133817
No abstract available.
2.
Juhan-Vague I, Vague P, Alessi M, Badier C, Valadier J, Aillaud M, et al.
Diabete Metab
. 1987 Jul;
13(3 Pt 2):331-6.
PMID: 3115843
Low fibrinolytic activity, as measured by euglobulin (EFA), has been observed in obese subjects, and hypofibrinolysis may play a role in the pathogenesis of atherosclerosis and its complications. Blood fibrinolytic...
3.
Vague P, Juhan-Vague I, Alessi M, Badier C, Valadier J
Thromb Haemost
. 1987 Jun;
57(3):326-8.
PMID: 3310318
We have previously observed a positive correlation between Plasminogen Activator Inhibition capacity (PA Inhibition), Body Mass Index (BMI) and plasma insulin levels in a population of non diabetic subjects. The...
4.
Juhan-Vague I, Valadier J, Alessi M, Aillaud M, Ansaldi J, Holvoet P, et al.
Thromb Haemost
. 1987 Feb;
57(1):67-72.
PMID: 3109059
The fibrinolytic system was investigated in 120 patients with spontaneous or recurrent deep vein thrombosis (DVT) without any known organic disease able to explain by itself the occurrence of a...
5.
Juhan-Vague I, Aillaud M, Valadier J, Alessi M, SERRADIMIGNI A
Ann Med Interne (Paris)
. 1986 Jan;
137(6):471-4.
PMID: 3101564
Quantitative abnormalities of fibrinolytic system factors (tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PA-inhibitor) are often found in the patients exhibiting an idiopathic thromboembolic pathology. Exploration of fibrinolytic system is...